Collaborative Practices and Preemptive Surveillance Reduce the Risk of Unrecognized Passenger Lymphocyte Syndrome in ABO Minor-Mismatched Stem Cell Transplantation

被引：0
|
作者：
Joshi, Sarita [1 ]
Dumont, Carol [2 ]
McCasson, Karen [2 ]
Gulyas, Margaret [2 ]
Figueroa, Priscilla I. [2 ]
机构：
[1] Cleveland Clin, Transfus Med Sect, Cleveland, OH 44106 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
来源：
TRANSFUSION | 2018年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TS55
引用
收藏
页码：114A / 114A
页数：1
相关论文
共 39 条
  • [31] Muticenter Retrospective Comparable Study of Prophylactic Versus Preemptive Modified Donor Lymphocyte Infusion for Patients with High-Risk Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Yang, Luxin
    Lai, Xiaoyu
    Yang, Ting
    Lu, Ying
    Liu, Lizhen
    Shi, Jimin
    Zhao, Yanmin
    Wu, Yibo
    Chen, Yi
    Yu, Jian
    Xiao, Haowen
    Ouyang, Guifang
    Ren, Jinhua
    Cao, Junjie
    Hu, Yongxian
    Tan, Yamin
    Cai, Zhen
    Huang, He
    Luo, Yi
    BLOOD, 2022, 140 : 7676 - 7677
  • [32] Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Guillaume, Thierry
    Yakoub-Agha, Ibrahim
    Tabrizi, Reza
    Borel, Cecile
    Chevallier, Patrice
    Magro, Leonardo
    Vigouroux, Stephane
    Peterlin, Pierre
    Garnier, Alice
    Rubio, Marie-Therese
    Huynh, Anne
    Milpied, Noel
    Moreau, Philippe
    Mohty, Mohamad
    BLOOD, 2016, 128 (22)
  • [33] Pre-Emptive Therapy with Modified Donor Lymphocyte Infusion Could Reduce Relapse and Improve Survival in Standard-Risk Acute Leukemia Patients After Allogeneic Hematopoiefic Stem Cell Transplantation
    Yan, Chenhua
    Liu, Daihong
    Xu, Lanping
    Liu, Kaiyan
    Chen, Huan
    Han, Wei
    Wang, Yu
    Huang, Xiaojun
    BLOOD, 2011, 118 (21) : 301 - 302
  • [34] On behalf of the SFGM-TC: prophylactic donor lymphocyte infusion in patients treated with allogeneic stem-cell transplantation for high-risk myelodysplastic syndrome and acute myeloid leukemia
    Guisnel, Charles
    Schirmer, Luciane
    Morisset, Stephane
    Robin, Marie
    Labussiere-Wallet, Helene
    Dulery, Remy
    Ceballos, Patrice
    Forcade, Edouard
    Nguyen-Quoc, Stephanie
    Poire, Xavier
    Maertens, Johan
    Chantepie, Sylvain
    Chevallier, Patrice
    Daguindau, Etienne
    Villate, Alban
    Charbonnier, Amandine
    Castilla-Llorente, Cristina
    Contentin, Nathalie
    Huynh, Anne
    Yakoub-Agha, Ibrahim
    Bulabois, Claude-Eric
    Rubio, Marie-Therese
    D'Aveni, Maud
    ACTA HAEMATOLOGICA, 2023, 146 (03) : 230 - 239
  • [35] EARLY LOW DOSE CYCLOSPORINE AND MYCOPHENOLATE REDUCE THE RISK OF CYTOKINE RELEASE SYNDROME AFTER HLA-HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION WITH PTCY BASED GVHD PROPHYLAXIS
    Vydra, Jan
    Novakova, Ludmila
    Valkova, Veronika
    Markova, Marketa Stastna
    Koubova, Mariana
    Dobrovolna, Anna
    Cemusova, Barbora
    Vitek, Antonin
    Cetkovsky, Petr
    BONE MARROW TRANSPLANTATION, 2024, 59 : 567 - 567
  • [36] Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome
    Schmid, C
    Schleuning, M
    Ledderose, G
    Tischer, J
    Kolb, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5675 - 5687
  • [37] Double infusion (days 0 and 4) of ex vivo expanded third party mesenchymal stem cells to reduce the risk of graft failure and graft-versus-host disease in mismatched sibling donor bone marrow transplantation for Hurler's syndrome
    Abecasis, M.
    Lobato, C.
    Ferreira, I.
    Sequeira, S.
    Miranda, N.
    Costa, F.
    Teixeira, G.
    Fernandez, E.
    Cabral, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S423 - S423
  • [38] Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
    Thierry Guillaume
    Florent Malard
    Leonardo Magro
    Myriam Labopin
    Reza Tabrizi
    Cécile Borel
    Patrice Chevallier
    Stéphane Vigouroux
    Pierre Peterlin
    Alice Garnier
    Marie-Thérèse Rubio
    Anne Huynh
    Noël Milpied
    Philippe Moreau
    Béatrice Gaugler
    Ibrahim Yakoub-Agha
    Mohamad Mohty
    Bone Marrow Transplantation, 2019, 54 : 1815 - 1826
  • [39] Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
    Guillaume, Thierry
    Malard, Florent
    Magro, Leonardo
    Labopin, Myriam
    Tabrizi, Reza
    Borel, Cecile
    Chevallier, Patrice
    Vigouroux, Stephane
    Peterlin, Pierre
    Garnier, Alice
    Rubio, Marie-Therese
    Huynh, Anne
    Milpied, Noel
    Moreau, Philippe
    Gaugler, Beatrice
    Yakoub-Agha, Ibrahim
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2019, 54 (11) : 1815 - 1826
1234